Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03556228
Title Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors VM Oncology, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Cancer Institute at Memorial Healthcare Systems RECRUITING Pembroke Pines Florida 33028 United States Details
Englewood Hospital and Medical Center RECRUITING Englewood New Jersey 07631 United States Details
Summit Medical Group RECRUITING Florham Park New Jersey 07932 United States Details
Atlantic Health System, Morristown Medical Center RECRUITING Morristown New Jersey 07962 United States Details
Cayuga Medical Center RECRUITING Ithaca New York 14850 United States Details
Weill Cornell Medicine, Cornell University RECRUITING New York New York 10065 United States Details
Taylor Cancer Research Center RECRUITING Maumee Ohio 43537 United States Details
Cancer Care Associates of York RECRUITING York Pennsylvania 17403 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Utah Cancer Specialists RECRUITING Salt Lake City Utah 84106 United States Details
Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
PanOncology Trials, Hospital Oncologico - Puerto Rico Medical Center, Río Piedras RECRUITING San Juan 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field